Contact

Start a conversation.

Interested in investing, collaborating, researching with us or exploring clinical use?

Direct contact

Pierrette Hebga Meinrad

Founder & CEO

hello@mylenium.co.uk LinkedIn

Mylenium pre-seed

£700k

Round opening October 2026

We are raising to build the clinical-grade platform, generate patient and clinician evidence, progress the regulatory pathway and prepare for first clinical deployment.